Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT

Key facts

Sponsor

All India Institute of Medical Sciences

Principal Investigator

Sheffali Gulati, MD

AIIMS, New Delhi

Intervention

7 days of albendazole 15 mg/kg/day(drug)

Enrollment

97 enrolled

Eligibility

2-18 years · All sexes

Timeline

2014 – 2015

Study locations (1)

• sheffali Gulati, New Delhi, National Capital Territory of Delhi, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Cysticercosis

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT00001205
  Natural History of Treated Neurocysticercosis and Long-Term Outcomes
  National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Cysticercosis →